Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E‐4031 from HERG to M‐eag channels

1 The gating behaviour and pharmacological sensitivity of HERG are remarkably different from the corresponding properties of M‐eag, a structurally similar member of the Eag family of potassium channels. In contrast to HERG, M‐eag exhibits no apparent inactivation and little rectification, and is insensitive to the class III antiarrhythmic drug E‐4031. 2 We generated chimeric channels of HERG and M‐eag sequences and made point mutations to identify the region necessary for rapid inactivation in HERG. This region includes the P region and half of the S6 putative transmembrane domain, including sites not previously associated with inactivation and rectification in HERG. 3 Transfer of a small segment of the HERG polypeptide to M‐eag, consisting largely of the P region and part of the S6 transmembrane domain, is sufficient to confer rapid inactivation and E‐4031 sensitivity to M‐eag. This region differs from the corresponding region in M‐eag by only fifteen residues. 4 Previous hypotheses that rapid inactivation of HERG channels occurs by a C‐type inactivation mechanism are supported by the parallel effects on rates of HERG inactivation and Shaker C‐type inactivation by a series of mutations at two equivalent sites in the polypeptide sequences. 5 In addition to sites homologous to those previously described for C‐type inactivation in Shaker, inactivation in HERG involves a residue in the upstream P region not previously associated with C‐type inactivation. Although this site is equivalent to one implicated in P‐type inactivation in Kv2.1 channels, our data are most consistent with a single, C‐type inactivation mechanism.

[1]  Gary Yellen,et al.  The inward rectification mechanism of the HERG cardiac potassium channel , 1996, Nature.

[2]  J. López-Barneo,et al.  Pore mutations in Shaker K+ channels distinguish between the sites of tetraethylammonium blockade and C‐type inactivation. , 1997, The Journal of physiology.

[3]  F. Bezanilla,et al.  S4 mutations alter gating currents of Shaker K channels. , 1994, Biophysical journal.

[4]  Y. Jan,et al.  Alteration of voltage-dependence of Shaker potassium channel by mutations in the S4 sequence , 1991, Nature.

[5]  T Hoshi,et al.  Shaker potassium channel gating. II: Transitions in the activation pathway , 1994, The Journal of general physiology.

[6]  A. Brown,et al.  Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. , 1996, Circulation.

[7]  B Attali,et al.  The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes , 1997, British journal of pharmacology.

[8]  R. North,et al.  Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels. , 1991, The Journal of biological chemistry.

[9]  J. Warmke,et al.  A family of potassium channel genes related to eag in Drosophila and mammals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Sanguinetti,et al.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.

[11]  R.,et al.  Ion Channels , 1996, Ion Channels.

[12]  Yu Huang,et al.  Electrostatic interactions of S4 voltage sensor in shaker K+ channel , 1995, Neuron.

[13]  K. Yau,et al.  Calcium-Calmodulin Modulation of the Olfactory Cyclic Nucleotide-Gated Cation Channel , 1994, Science.

[14]  G. Robertson,et al.  HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.

[15]  R. Reed,et al.  Identification of Functional Domains of Adenylyl Cyclase Using in Vivo Chimeras (*) , 1995, The Journal of Biological Chemistry.

[16]  R. MacKinnon,et al.  Mutations affecting TEA blockade and ion permeation in voltage-activated K+ channels. , 1990, Science.

[17]  R. Aldrich,et al.  Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. , 1993, Receptors & channels.

[18]  M. Sanguinetti,et al.  Fast inactivation causes rectification of the IKr channel , 1996, The Journal of general physiology.

[19]  S. Heinemann,et al.  Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. , 1996, The Journal of physiology.

[20]  R. MacKinnon,et al.  Mutations affecting internal TEA blockade identify the probable pore-forming region of a K+ channel , 1991, Science.

[21]  Richard W. Aldrich,et al.  Two types of inactivation in Shaker K+ channels: Effects of alterations in the carboxy-terminal region , 1991, Neuron.

[22]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[23]  S. Amara,et al.  Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Liman,et al.  Voltage-sensing residues in the S4 region of a mammalian K+ channel , 1991, Nature.

[25]  H. Strauss,et al.  A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes , 1997, The Journal of physiology.

[26]  R. Blakely,et al.  Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs. , 1994, BioTechniques.

[27]  F Bezanilla,et al.  Gating of Shaker K+ channels: II. The components of gating currents and a model of channel activation. , 1994, Biophysical journal.

[28]  G. Robertson,et al.  HERG sequence correction. , 1996, Science.

[29]  E. Wright,et al.  Molecular evidence for two renal Na+/glucose cotransporters. , 1992, Biochimica et biophysica acta.

[30]  A Gibbons.  Our chimp cousins get that much closer , 1990, Science.

[31]  H. Guy,et al.  Structural Model of the Outer Vestibule and Selectivity Filter of the Shaker Voltage-gated K+ Channel , 1996, Neuropharmacology.

[32]  C. January,et al.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.

[33]  A. Brown,et al.  Exchange of conduction pathways between two related K+ channels , 1991, Science.

[34]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[35]  M. Tanouye,et al.  The size of gating charge in wild-type and mutant Shaker potassium channels. , 1992, Science.

[36]  K. Lindpaintner,et al.  Incremental reductions of positive charge within the S4 region of a voltage-gated K+ channel result in corresponding decreases in gating charge , 1992, Neuron.

[37]  N. Copeland,et al.  Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. , 1997, Circulation research.

[38]  M. Sanguinetti,et al.  Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. , 1996, Circulation research.

[39]  R. Drysdale,et al.  A distinct potassium channel polypeptide encoded by the Drosophila eag locus , 1991, Science.

[40]  J. Warmke,et al.  Potassium Currents Expressed from Drosophila and Mouse eag cDNAs in Xenopus Oocytes , 1996, Neuropharmacology.

[41]  R. MacKinnon,et al.  Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor. , 1989, Science.

[42]  H. Strauss,et al.  Time, voltage and ionic concentration dependence of rectification of h‐erg expressed in Xenopus oocytes , 1996, FEBS letters.

[43]  T. Shibasaki,et al.  Conductance and kinetics of delayed rectifier potassium channels in nodal cells of the rabbit heart. , 1987, The Journal of physiology.

[44]  J. Tytgat,et al.  Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs , 1992, Neuron.

[45]  R. MacKinnon,et al.  Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor , 1990, Neuron.